How did Israel’s strike on Iran impact oil prices?
Why are US stock futures falling after Middle East attacks?
What caused the drop in Tesla's stock today?
How will Meta’s investment in Scale AI affect AI development?
Why is JPMorgan warning about $120 oil prices?
What led to JBS’s NYSE debut and investor concerns?
How are tariffs affecting innovation at small businesses?
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
benzinga.com/markets/large-cap/25/06/45912248/novartis-fabhalta-delivers-hemoglobin-gains-reduces-fatigue-in-patients-with-rare-blood-disorde
Novartis AG (NYSE:NVS) on Thursday released results from APPULSE-PNH, a Phase 3B study evaluating the efficacy and safety of twice-daily oral monotherapy Fabhalta (iptacopan) in adult patients with paroxysmal nocturnal hemoglobinuria (PNH) with Hb levels ≥10g/dL who switched from anti-C5…
This story appeared on benzinga.com, 2025-06-12 18:25:16.